Comment by
Noteable on Aug 10, 2022 11:07am
Should read: BMS enters into a USD$ 2 Billion deal with startup company
Comment by
Lesalpes29 on Aug 10, 2022 11:24am
No more blah blah blah... NR from onc is what we need!
Comment by
fox7mf on Aug 10, 2022 12:07pm
100% agreed. Let's get an NR followed by posts about Oncy being acquired or partnered. BP is throwing massive amounts of cash around, but none towards us...yet. Reading about start-ups and preclinical companies getting multi billions is getting unnerving. Coffey...Parsons...get the sale done!!
Comment by
Buckhenry on Aug 10, 2022 12:24pm
But we would not have anything to read on here if we restricted it to oncy only?? ???
Comment by
Lesalpes29 on Aug 10, 2022 12:56pm
You understand very well what I think.
Comment by
fox7mf on Aug 10, 2022 2:25pm
Geeez, I wasn't trying to spark a whole brouhaha here...I'm not sure anybody was. I'm on record for being super bullish on Onc. Noteable, I'm also in agreement with your $8b-$15busd assessment of Oncy's value at acquisition. I'm just a little weary of all the BP spending not involving us.
Comment by
Noteable on Aug 13, 2022 8:08pm
There is no need to strategize when Big Pharma companies are acquiring 2 year old start-up companies for USD$ 2+ Billion